Deoxyschizandrin ameliorates obesity and non‐alcoholic fatty liver disease: Involvement of dual Farnesyl X receptor/G protein‐coupled bile acid receptor 1 activation and leptin sensitization
出版年份 2023 全文链接
标题
Deoxyschizandrin ameliorates obesity and non‐alcoholic fatty liver disease: Involvement of dual Farnesyl X receptor/G protein‐coupled bile acid receptor 1 activation and leptin sensitization
作者
关键词
-
出版物
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-02-22
DOI
10.1002/ptr.7770
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases
- (2022) Vasanti S. Malik et al. Nature Reviews Endocrinology
- The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
- (2022) Kiarash Riazi et al. Lancet Gastroenterology & Hepatology
- The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
- (2021) Lulu Sun et al. Nature Reviews Gastroenterology & Hepatology
- Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors
- (2021) Marica Cariello et al. Cellular and Molecular Gastroenterology and Hepatology
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Hypothalamic bile acid-TGR5 signaling protects from obesity
- (2021) Ashley Castellanos-Jankiewicz et al. Cell Metabolism
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- Bile acids and their receptors in metabolic disorders
- (2021) Stefano Fiorucci et al. PROGRESS IN LIPID RESEARCH
- Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
- (2021) Sachiho Miyata et al. Scientific Reports
- FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption
- (2021) Bethan L. Clifford et al. Cell Metabolism
- Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
- (2021) Daniel Ferguson et al. Nature Reviews Endocrinology
- Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
- (2021) Rui Xue et al. Cells
- Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
- (2020) John Y. L. Chiang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The effect of deoxyschizandrin on chronic unpredictable mild stress–induced depression
- (2020) Xinfei Ma et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Extract of Schisandra chinensis fruit protects against metabolic dysfunction in high‐fat diet induced obese mice via FXR activation
- (2020) Ming Gu et al. PHYTOTHERAPY RESEARCH
- Pharmacodynamic effects and molecular mechanisms of lignans from Schisandra chinensis Turcz. (Baill.), a current review
- (2020) Yuan Zhou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Schizandrin A supplementation improves non-alcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet
- (2019) Mi Ji Jeong et al. NUTRITION RESEARCH
- Obesity: global epidemiology and pathogenesis
- (2019) Matthias Blüher Nature Reviews Endocrinology
- Schisandrin A ameliorates MPTP-induced Parkinson’s disease in a mouse model via regulation of brain autophagy
- (2019) Yinghao Zhi et al. ARCHIVES OF PHARMACAL RESEARCH
- Obesity: a neuroimmunometabolic perspective
- (2019) Chelsea M. Larabee et al. Nature Reviews Endocrinology
- INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function
- (2018) Paolo Comeglio et al. JOURNAL OF ENDOCRINOLOGY
- Leptin and the maintenance of elevated body weight
- (2018) Warren W. Pan et al. NATURE REVIEWS NEUROSCIENCE
- Leptin and brain–adipose crosstalks
- (2018) Alexandre Caron et al. NATURE REVIEWS NEUROSCIENCE
- Hypothalamic Sensing of Bile Acids, a Gut Feeling
- (2018) Allison W. Xu TRENDS IN ENDOCRINOLOGY AND METABOLISM
- INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
- (2018) Jonathan D Roth et al. WORLD JOURNAL OF GASTROENTEROLOGY
- TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue
- (2018) Laura A. Velazquez-Villegas et al. Nature Communications
- A gut–brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus
- (2018) Shunmei Liu et al. Molecular Metabolism
- Small molecules for fat combustion: targeting obesity
- (2018) Jingxin Liu et al. Acta Pharmaceutica Sinica B
- Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
- (2017) Oscar Chávez-Talavera et al. GASTROENTEROLOGY
- Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism
- (2017) Preeti Pathak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The cellular and molecular bases of leptin and ghrelin resistance in obesity
- (2017) Huxing Cui et al. Nature Reviews Endocrinology
- Clinical relevance of the bile acid receptor TGR5 in metabolism
- (2017) F Samuel van Nierop et al. Lancet Diabetes & Endocrinology
- Euglycemia Restoration by Central Leptin in Type 1 Diabetes Requires STAT3 Signaling but Not Fast-Acting Neurotransmitter Release
- (2016) Yuanzhong Xu et al. DIABETES
- An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
- (2016) Frank J. Gonzalez et al. GASTROENTEROLOGY
- Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice
- (2016) Jaemin Lee et al. NATURE MEDICINE
- Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
- (2015) John C McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Treatment of Obesity with Celastrol
- (2015) Junli Liu et al. CELL
- Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation
- (2015) Yiming Jiang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- Bile acid receptors as targets for drug development
- (2013) Frank G. Schaap et al. Nature Reviews Gastroenterology & Hepatology
- Sexually Dimorphic Genome-Wide Binding of Retinoid X Receptor alpha (RXRα) Determines Male-Female Differences in the Expression of Hepatic Lipid Processing Genes in Mice
- (2013) Astrid Kosters et al. PLoS One
- Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis
- (2011) Xuemei Ge et al. JOURNAL OF LIPID RESEARCH
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- Bile acid-activated receptors in the treatment of dyslipidemia and related disorders
- (2009) Stefano Fiorucci et al. PROGRESS IN LIPID RESEARCH
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More